BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260813T100000
DTEND;TZID=America/Los_Angeles:20260813T120000
DTSTAMP:20260630T200519Z
CREATED:20260629T132259Z
LAST-MODIFIED:20260630T200519Z
UID:10668-1786615200-1786622400@thebiocalendar.com
SUMMARY:Commercial Readiness Solutions
DESCRIPTION:The journey from a successful lab result to a reliable\, GMP-compliant product is rarely a straight line. It’s a transition filled with technical hurdles\, regulatory pressure\, and the constant challenge of scaling without compromise. \nWe created the Commercial Readiness Solutions session to help you navigate this transition. This virtual event is designed to be highly practical – moving past high-level theory to focus on the specific tools and partnerships needed to solve the real-world bottlenecks in your production lifecycle. \nJoin us to evaluate the solutions and technologies essential for a sustainable commercial platform\, including: \nGMP Execution & Inspection Readiness: Building the protocols and confidence to meet global regulatory standards.\nManufacturing Scale-up: Leveraging closed-system automation to reduce manual risk and variability.\nContamination Control: Implementing advanced strategies to ensure sterility and product safety at scale.\nQC & Release Testing: Optimizing testing strategies to accelerate the path from the facility to the patient.\nValidation & Data Integrity: Ensuring your process documentation is robust\, transparent\, and compliant.\nDigital Infrastructure: Integrating eQMS\, MES\, and LIMS for a seamless\, paperless manufacturing environment. \nPractical Insights\, Not Just Presentations. Through solution-focused sessions and real-world case studies\, this event will highlight the supplier capabilities and technologies that reduce risk and accelerate your timelines. Our goal is to show you how to strengthen your operational resilience – maintaining the highest quality standards without sacrificing the throughput you need to stay competitive. \nMove Forward with Confidence. Whether you are preparing for your next inspection\, refining your control strategy\, or building a repeatable platform for the global market\, we are here to connect you with the right expertise. Join us to find the tools and insights you need to move confidently from development to commercial success – bringing life-changing therapies to more patients\, faster.
URL:https://thebiocalendar.com/event/commercial-readiness-solutions/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/06/08-2026-CGTE-1280x720-COMMERCIAL-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260813T110000
DTEND;TZID=America/Los_Angeles:20260813T120000
DTSTAMP:20260725T055907Z
CREATED:20260721T175625Z
LAST-MODIFIED:20260725T055907Z
UID:10806-1786618800-1786622400@thebiocalendar.com
SUMMARY:When Unexpected Particles Threaten Your Biologic
DESCRIPTION:Unexpected particle findings can raise critical questions about product quality\, patient safety\, and regulatory compliance. \nJoin KBI Biopharma’s experts to learn how clinical in-use studies and advanced particle forensics can help identify particle sources\, assess risk\, and build regulator-ready evidence for confident decision-making. \nRegister now to discover practical strategies for accelerating investigations\, supporting development timelines\, and responding effectively when unexpected particles threaten your biologic.
URL:https://thebiocalendar.com/event/when-unexpected-particles-threaten-your-biologic/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-13-26-KBI-eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260813T130000
DTEND;TZID=America/Los_Angeles:20260813T140000
DTSTAMP:20260714T195655Z
CREATED:20260714T125112Z
LAST-MODIFIED:20260714T195655Z
UID:10770-1786626000-1786629600@thebiocalendar.com
SUMMARY:From Data to Decisions: AI and Multi-Omics for Cell Culture Development
DESCRIPTION:As biologics developers work to improve productivity\, maintain product quality\, and accelerate development timelines\, traditional optimization approaches can sometimes reach a point of diminishing returns. While cell culture processes generate vast amounts of biological and process data\, extracting actionable insights from that information remains a significant challenge. \nIn this webinar\, Thermo Fisher Scientific specialists discuss how the integration of multi-omics data\, artificial intelligence (AI)\, and deep cell culture expertise can help uncover the biological mechanisms driving process performance. Learn how AI-enabled analytics can support more informed decision-making\, identify optimization opportunities\, and accelerate media and process development. \nIn this session\, you will learn about:\n~ The role of multi-omics in understanding cell culture performance\n~ How AI is helping uncover biological drivers of productivity and quality\n~ Emerging applications of predictive modeling in media and process development\n~ New approaches to turning complex biological data into actionable insights \nKey topics include:\n~ Case study: using AI and metabolomics to overcome optimization plateaus\n~ Multi-omics approaches in cell culture development\n~ AI-enabled data integration and pattern recognition\n~ Understanding productivity and product quality trade-offs\n~ From biological data to development decisions \nDiscover how AI and multi-omics are helping developers move beyond descriptive analytics toward more predictive\, mechanism-based approaches to cell culture optimization.
URL:https://thebiocalendar.com/event/from-data-to-decisions-ai-and-multi-omics-for-cell-culture-development/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/07/08-13-26-Thermo-Reg-1920x250-1.png
END:VEVENT
END:VCALENDAR